Why the study?
Resistant hypertension is difficult to control despite multiple antihypertensive drugs and is linked to target organ damage, prompting the need for non-invasive alternatives like transcutaneous electrical nerve stimulation to lower blood pressure.
Does transcutaneous electrical nerve stimulation (TENS) reduce blood pressure in a patient with resistant hypertension?
Does transcutaneous electrical nerve stimulation (TENS) reduce blood pressure in a patient with resistant hypertension?
TENS applied to the stellate ganglion may reduce peripheral and central blood pressure in patients with resistant hypertension, offering a potential non-invasive adjunctive therapy.
Supports TENS exploration in resistant hypertension; hypothesis-generating and requires RCTs before any clinical adoption.
Resistant hypertension (RH) is characterized by being difficult to control, even with the use of various antihypertensive drugs and is associated with target organ lesions and other comorbidities. Thus, new treatment alternatives such as transcutaneous electrical nerve stimulation (TENS) can offer benefits to resistant hypertensive patients by reducing blood pressure (BP) in a non-invasive way and without the need for the association of more antihypertensive drugs. In this case, a patient with RH was submitted to three weekly applications of TENS on the stellate ganglion lasting 40 min each for 1 month. Peripheral and central hemodynamic assessments were performed by 24-h ambulatory BP monitoring (ABPM) before and after TENS applications. After completion of the TENS applications, significant reductions in office systolic (SBP) and diastolic BP (DBP) were observed. There was also a decrease in peripheral SBP and DBP in the 24-h ABPM and sleep and SBP during wakefulness. Additionally, central parameters including central SBP and pulse wave velocity presented a significant reduction in the 24-h ABPM, during the wakefulness and sleep. TENS is able to attenuate the sympathetic hyperactivity present in RH cases and decrease the peripheral and central hemodynamic parameters of a resistant hypertensive patient.
No takes yet. Share an insight, caveat, or question.
Giollo-Junior et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: